Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.76B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$776M |
| 3 |
Alibaba
BABA
|
+$405M |
| 4 |
Stellantis
STLA
|
+$331M |
| 5 |
First Horizon
FHN
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Microsoft
MSFT
|
+$1.8B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$982M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 10.55% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XPOA
2176
DELISTED
DPCM Capital, Inc.
XPOA
| $1.07M | ﹤0.01% |
+108,287
| New | +$1.07M |
|
2177
Power Integrations
POWI
$2.5B
| $1.07M | ﹤0.01% |
11,531
-72,676
| -86% | -$6.73M |
|
2178
Enanta Pharmaceuticals
ENTA
$161M
| $1.07M | ﹤0.01% |
14,970
-10,068
| -40% | -$717K |
|
2179
Mesa Laboratories
MLAB
$358M
| $1.07M | ﹤0.01% |
4,184
-2,322
| -36% | -$592K |
|
2180
The RealReal
REAL
$1.2B
| $1.07M | ﹤0.01% |
146,558
-17,619
| -11% | -$128K |
|
2181
Amkor Technology
AMKR
$6.58B
| $1.06M | ﹤0.01% |
49,030
-99,604
| -67% | -$2.16M |
|
2182
CERo Therapeutics
CERO
$6.65M
| $1.06M | ﹤0.01% |
+53
| New | +$1.06M |
|
2183
Chefs' Warehouse
CHEF
$2.75B
| $1.06M | ﹤0.01% |
32,559
-13,939
| -30% | -$455K |
|
2184
Phreesia
PHR
$1.39B
| $1.06M | ﹤0.01% |
+40,310
| New | +$1.06M |
|
2185
iShares MSCI Malaysia ETF
EWM
$249M
| $1.06M | ﹤0.01% |
+41,340
| New | +$1.06M |
|
2186
HealthEquity
HQY
$7.95B
| $1.06M | ﹤0.01% |
15,673
-98,018
| -86% | -$6.61M |
|
2187
Rayonier Advanced Materials
RYAM
$466M
| $1.06M | ﹤0.01% |
160,809
+79,939
| +99% | +$525K |
|
|
JUGG
2188
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $1.06M | ﹤0.01% |
+108,400
| New | +$1.06M |
|
|
CCXI
2189
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.06M | ﹤0.01% |
42,112
-109,104
| -72% | -$2.74M |
|
2190
Core Laboratories
CLB
$585M
| $1.06M | ﹤0.01% |
33,405
+29,145
| +684% | +$921K |
|
2191
Enerpac Tool Group
EPAC
$2.28B
| $1.06M | ﹤0.01% |
+48,281
| New | +$1.06M |
|
2192
Appian
APPN
$2.33B
| $1.05M | ﹤0.01% |
17,349
-92,572
| -84% | -$5.62M |
|
2193
Protagonist Therapeutics
PTGX
$3.68B
| $1.05M | ﹤0.01% |
44,302
-76,295
| -63% | -$1.81M |
|
2194
Avient
AVNT
$3.29B
| $1.05M | ﹤0.01% |
+21,868
| New | +$1.05M |
|
2195
America Movil
AMX
$61.8B
| $1.05M | ﹤0.01% |
49,392
+19
| +0% | +$402 |
|
2196
Steelcase
SCS
$1.92B
| $1.04M | ﹤0.01% |
87,292
-62,750
| -42% | -$750K |
|
2197
Valvoline
VVV
$5.15B
| $1.04M | ﹤0.01% |
33,047
-76,654
| -70% | -$2.42M |
|
2198
Better Home & Finance Holding
BETR
$432M
| $1.04M | ﹤0.01% |
+2,113
| New | +$1.04M |
|
2199
ProShares UltraPro Short QQQ
SQQQ
$2.17B
| $1.04M | ﹤0.01% |
+6,180
| New | +$1.04M |
|
2200
Aclaris Therapeutics
ACRS
$196M
| $1.04M | ﹤0.01% |
60,256
-40,262
| -40% | -$694K |
|